Bayer Pakistan’s Pharmaceutical Division has announced the commercial launch of a new medication for the treatment of endometriosis, further strengthening its women’s healthcare portfolio.

Endometriosis is a painful inflammatory condition that affects women of reproductive age, most commonly between 20 and 45 years. It occurs when tissue similar to the uterine lining grows outside the uterus, leading to inflammation and the formation of scar tissue. The condition can cause chronic pelvic pain, heavy bleeding during or between periods and fertility........

© Dawn